Skip to main content
An official website of the United States government

Early Detection Research Network (EDRN)

The Early Detection Research Network (EDRN) is a collaborative program that maintains comprehensive infrastructure and resources critical to the discovery, development and validation of biomarkers for cancer risk and early detection.

The DCP Cancer Biomarkers Research Group administers this program.

On This Page

  • All Heading 2s will automatically be pulled in to this list.
  • Do not edit the content on this template.

About EDRN

The program comprises a public/private sector consortium to accelerate the development of biomarkers that can improve medical practice, ensure data reproducibility and integrity, and adapt to the changing landscape of biomarker science.

Visit the EDRN Website

Grantee Details

PI Name Sort descending PI Organization Title Grant Number Program Official
Perez-Lougee, Giselle Katiria

Massachusetts General Hospital
United States

Thriving Beyond Treatment: A Resilience-Based Approach to Improve Long-term Quality of Life in Post-treatment Lymphoma Survivorship 1R37CA303094-01 Marjorie Perloff, M.D.
Perez-Lougee, Giselle Katiria

Massachusetts General Hospital
United States

Thriving Beyond Treatment: A Resilience-Based Approach to Improve Long-term Quality of Life in Post-treatment Lymphoma Survivorship 1R37CA303094-01 Marjorie Perloff, M.D.
Perkins, Susan M

Indiana University Indianapolis
United States

Evaluation of the Communication Plan Early through End-of-Life (COMPLETE) Intervention 5R01CA235632-06 Brennan Streck, Ph.D., RN, M.P.H.
Perkins, Susan M

Indiana University Indianapolis
United States

Evaluation of the Communication Plan Early through End-of-Life (COMPLETE) Intervention 5R01CA235632-06 Brennan Streck, Ph.D., RN, M.P.H.
Permuth, Jennifer B

H. Lee Moffitt Cancer Ctr & Res Inst
United States

Using Radiogenomics to Noninvasively Predict the Malignant Potential of Intraductal Papillary Mucinous Neoplasms of the Pancreas and Uncover Hidden Biology 5R37CA229810-07 Matthew Young, Ph.D.
Peters, Jeffrey M

Pennsylvania State University, The
United States

Unique targeting of PPARβ/δ regulation for cancer prevention and therapy 5R01CA239256-05 Marjorie Perloff, M.D.
Pfleger, Cathie M

Icahn School Of Medicine At Mount Sinai
United States

A Drosophila model for Aromatase Inhibitor-induced Musculoskeletal Pain 1R21CA303409-01 Rachel Altshuler, Ph.D.
Pfleger, Cathie M

Icahn School Of Medicine At Mount Sinai
United States

A Drosophila model for Aromatase Inhibitor-induced Musculoskeletal Pain 1R21CA303409-01 Rachel Altshuler, Ph.D.
Phillips, Nicholas S

St. Jude Children'S Research Hospital
United States

Cardiopulmonary function and cerebral blood flow in Hodgkin Lymphoma survivors 5R21CA280230-02 Eileen Dimond, R.N., M.S.
Phillips, Nicholas S

St. Jude Children'S Research Hospital
United States

Cardiopulmonary function and cerebral blood flow in Hodgkin Lymphoma survivors 5R21CA280230-02 Eileen Dimond, R.N., M.S.
Pinder, Leeya F

University Of Cincinnati
United States

RepurPosed AntiretrOviraL ThErapieS to EliminAte Cervical Cancer (POLESA Trial) 3R37CA284033-03S1 Vikrant Sahasrabuddhe, M.B.B.S., M.P.H., Dr.P.H.
Pistilli, Emidio Edward

West Virginia University
United States

Targeting Muscle Fatigability During Cachexia 5R01AR079445-04 Brandy Heckman-Stoddard, Ph.D., M.P.H.
Pistilli, Emidio Edward

West Virginia University
United States

Targeting Muscle Fatigability During Cachexia 5R01AR079445-04 Brandy Heckman-Stoddard, Ph.D., M.P.H.
Pitteri, Sharon

Stanford University
United States

Glycosylation and Immune Evasion in Urologic Tumors 5U01CA226051-05
Plas, Ellen Van Der

Arkansas Children'S Hospital Res Inst
United States

Identifying markers of abnormal neurocognitive trajectories during chemotherapy treatment of childhood acute lymphoblastic leukemia 5R37CA266135-04 Asad Umar, D.V.M., Ph.D.